Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COX7C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HNRNPA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPYL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CBX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506718 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1143 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929087 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NORAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2Q2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on